Stephen Nicholls

Victorian Heart Hospital and Victorian Heart Institute · company speakers →

pharma-biotechhealthcare-services

Is this you? Claim this profile →

No public contact links on file.

Speaking history

Basic Cardiovascular Sciences Scientific Sessions

13 July 2026 Boston, United States “ANGPTL3 First-in-Human Phase 1 Clinical Trial of a CRISPR-Cas9 Gene Editing Therapy Targeting ANGPTL3”

Topics this speaker covers

pharma-biotechhealthcare-services

Sectors

healthcare_medtech_pharma

Sourcing speakers for your event?

Browse the speaker directory →